Compounds > 5,7-dihydroxytryptamine
Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Alloxan Diabetes

5,7-dihydroxytryptamine has been researched along with Alloxan Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, MT; Yang, YF1
Ahlers, ST; Bragin, V; Davis, KL; Gluck, R; Gotlib, J; Haroutunian, V; Shea, PA; Sugar, J; Wallace, W1

Other Studies

2 other study(ies) available for 5,7-dihydroxytryptamine and Alloxan Diabetes

ArticleYear
Brain serotonin depletion attenuates diabetogenic effects of streptozotocin.
    The American journal of physiology, 1995, Volume: 268, Issue:5 Pt 1

    Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Diabetes Mellitus, Experimental; Dopamine; Fenclonine; Male; p-Chloroamphetamine; Pancreas; Rats; Rats, Sprague-Dawley; Serotonin

1995
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-15, Volume: 90, Issue:18

    Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Actins; Afferent Pathways; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Diabetes Mellitus, Experimental; Functional Laterality; Glucocorticoids; Kinetics; Lidocaine; Male; N-Methylaspartate; Norepinephrine; Oxidopamine; Physostigmine; Polyribosomes; Raphe Nuclei; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Innominata; Time Factors

1993